Glimepiride / Pioglitazone Dosage
This dosage information may not include all the information needed to use Glimepiride / Pioglitazone safely and effectively. See additional information for Glimepiride / Pioglitazone.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Usual Adult Dose for:
Additional dosage information:
Usual Adult Dose for Diabetes Type 2
The initial dosage of glimepiride recommended for this patient with diabetes mellitus type II is based on the patient's current regime of pioglitazone and /or sulfonylurea.
For patients currently on glimepiride monotherapy, glimepiride-pioglitazone may be initiated at 30 mg/2 mg or 30 mg/4 mg tablet strengths once daily, and adjusted after assessing adequacy of therapeutic response.
For patients currently on pioglitazone monotherapy, glimepiride-pioglitazone may be initiated at 30 mg-2 mg or 30 mg-4 mg tablet strengths once daily, and adjusted after assessing adequacy of therapeutic response.
For patients currently on a different sulfonylurea monotherapy or switching from combination therapy of pioglitazone plus a different sulfonylurea (e.g. glyburide, glipizide, chlorpropamide, tolbutamide, acetohexamide), glimepiride-pioglitazone should be limited initially to a starting dose of 30 mg/2 mg once daily, and adjusted after assessing adequacy of therapeutic response.
For patients switching from combination therapy of pioglitazone plus glimepiride as separate tablets, glimepiride-pioglitazone may be initiated with 30 mg/2 mg or 30 mg/4 mg tablet strengths based on the dose of pioglitazone and glimepiride already being taken. Patients who are not controlled with 15 mg of pioglitazone in combination with glimepiride should be carefully monitored when switched to glimepiride-pioglitazone.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Therapy with glimepiride-pioglitazone should not be initiated if the patient exhibits clinical evidence of active liver disease or increased serum transaminase levels (ALT greater than 2.5 times the upper limit of normal) at start of therapy.
Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).
Data not available
Glimepiride-pioglitazone should be taken once daily with the first main meal. Glimepiride-pioglitazone should not be given more than once daily for any of the tablet strengths.
More about glimepiride/pioglitazone
- Glimepiride and pioglitazone
- Pioglitazone and glimepiride (Advanced Reading)
- Other brands: Duetact